Tobacco News and Research RSS Feed - Tobacco News and Research

Broad Institute expands collaboration with Bayer to develop new cardiovascular therapies

Broad Institute expands collaboration with Bayer to develop new cardiovascular therapies

The Broad Institute of MIT and Harvard have expanded their collaboration with Bayer HealthCare to include cardiovascular genomics and drug discovery. The goal of this new part of the alliance is to leverage insights from human genetics to help create new cardiovascular therapies. [More]
Study can aid in developing patient-centered interventions for seniors with asthma

Study can aid in developing patient-centered interventions for seniors with asthma

Although often considered a childhood health problem, asthma - a chronic inflammatory disease that causes recurrent cough, wheezing and chest tightness or shortness of breath - can cause serious illness for people age 60 and older, and little is known about the triggers of asthma specific to seniors. [More]
First global model for predicting CVD risk

First global model for predicting CVD risk

Researchers have developed the first global model for predicting cardiovascular disease (CVD) risk. The model—developed by Harvard T.H. Chan School of Public Health, Imperial College London, and colleagues—will be of particular help to public health professionals, clinicians, and patients in developing countries for prevention of CVD. [More]
Researchers find strong relationship between prenatal PAH exposure and behavioral impairment

Researchers find strong relationship between prenatal PAH exposure and behavioral impairment

Researchers at the Institute for the Developing Mind at Children's Hospital Los Angeles and colleagues at Columbia University's Center for Children's Environmental Health have found a powerful relationship between prenatal PAH exposure and disturbances in parts of the brain that support information processing and behavioral control. [More]
3D respiratory tissue model shown to be effective for measuring impact of chemicals

3D respiratory tissue model shown to be effective for measuring impact of chemicals

A 3-dimensional model of human respiratory tissue has been shown to be an effective platform for measuring the impact of chemicals, like those found in cigarette smoke, or other aerosols on the lung. [More]
ASH welcomes new anti-illicit tobacco strategy launched by Government

ASH welcomes new anti-illicit tobacco strategy launched by Government

ASH welcomed the Government’s refreshed anti-illicit tobacco strategy launched today. The new strategy had been pre-announced in the Budget, which noted that it would not only protect public finances but also “help meet public health objectives by driving down smoking prevalence.” [More]
Many teens still ignorant of significant physical danger posed by legal drugs

Many teens still ignorant of significant physical danger posed by legal drugs

Legal drugs such as OxyContin now kill more people than heroin and cocaine combined. While awareness of the dangers of illegal drugs has increased, many teens are still ignorant of the significant physical danger posed by legally prescribed drugs, according to a new study in Journal of Public Policy & Marketing. [More]
Obesity, smoking, alcohol abuse, depressive disorders are risk factors for low back pain

Obesity, smoking, alcohol abuse, depressive disorders are risk factors for low back pain

New research presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) identifies nicotine dependence, obesity, alcohol abuse and depressive disorders as risk factors for low back pain, a common condition causing disability, missed work, high medical costs and diminished life quality. [More]
Bloomberg Philanthropies introduces $100 million initiative to improve public health data collection

Bloomberg Philanthropies introduces $100 million initiative to improve public health data collection

Bloomberg Philanthropies, in partnership with the Australian government, is launching Data for Health, a $100 million initiative that will enable 20 low- and middle-income countries to vastly improve public health data collection. [More]
DaVita HealthCare Partners named Metro Denver's healthiest extra-large employer

DaVita HealthCare Partners named Metro Denver's healthiest extra-large employer

DaVita HealthCare Partners Inc., one of the nation's largest and most innovative health care communities, has been recognized by the Denver Business Journal as Metro Denver's healthiest extra-large employer. This is the fourth consecutive year the company has topped the list because of its commitment to teammate health and wellness. [More]
Stempeutics' Stempeucel drug receives ATMP classification from EMA for treatment of TAO

Stempeutics' Stempeucel drug receives ATMP classification from EMA for treatment of TAO

Stempeutics Research, a group company of Manipal Education and Medical Group and a Joint Venture with Cipla Group, announced today that the European Medicines Agency has granted Advanced Therapy Medicinal Product classification for its novel stem cell drug 'Stempeucel' which will be used for the treatment of Thromboangiitis Obliterans (TAO). [More]
MED15 may serve as prognostic marker for HNSCC recurrence

MED15 may serve as prognostic marker for HNSCC recurrence

A new study provides the first evidence that the mediator complex subunit 15 (MED15) may play a crucial role in the pathophysiology of head and neck squamous cell carcinoma (HNSCC). MED15 overexpression was found to be associated with higher mortality rates in HNSCC patients with cancer recurrence, particularly in oral cavity/oropharyngeal tumors, according to the study published in The American Journal of Pathology. [More]
Department of Health awarded American Cancer Society “Exemplary Leadership” award for tobacco policy achievements

Department of Health awarded American Cancer Society “Exemplary Leadership” award for tobacco policy achievements

In the week that the standardised tobacco packaging regulations passed into law, the UK Department of Health has been recognised as an International Tobacco Control Leader by the American Cancer Society. [More]
Semler receives 510(k) marketing clearance from FDA for next generation PAD testing system

Semler receives 510(k) marketing clearance from FDA for next generation PAD testing system

Semler Scientific, Inc., an emerging medical risk assessment company that develops, manufactures and markets patented products that assist healthcare providers in monitoring patients and evaluating chronic diseases, today announced receipt of 510(k) marketing clearance from the U.S. Food and Drug Administration for its next generation peripheral artery disease (PAD) testing system. [More]
American Cancer Society, World Lung Foundation unveil ‘The Tobacco Atlas, Fifth Edition’

American Cancer Society, World Lung Foundation unveil ‘The Tobacco Atlas, Fifth Edition’

The Tobacco Atlas, Fifth Edition ("The Atlas"), and its companion mobile app and website TobaccoAtlas.org, were unveiled today by the American Cancer Society and World Lung Foundation at the 16th World Conference on Tobacco or Health. [More]
Early repeat scan rate for lung cancer decreases by more than 80% with second LDCT screens

Early repeat scan rate for lung cancer decreases by more than 80% with second LDCT screens

The German Lung Cancer Screening Intervention Trial shows that the early repeat scan rate for suspicious findings decreased by more than 80% with the second and subsequent low-dose computed tomography (LDCT) screens, but emphasizes the need to have an organized screening program with the baseline scan available for comparison. [More]
Keas announces launch of Health Hub for self-insured employers

Keas announces launch of Health Hub for self-insured employers

Keas, the health management leader, today announced the launch of Health Hub, the first Health Management platform for self-insured employers. [More]
Hydrazine not prevalent in smokeless tobacco products

Hydrazine not prevalent in smokeless tobacco products

After many years of speculation, it has finally been established that hydrazine is not a prevalent contaminant in contemporary smokeless tobacco products (STPs). [More]

Money from proposed levy on tobacco industry sales must be spent on tobacco control measures

Money from a proposed new levy on the tobacco industry sales must be spent on reducing the harm that smoking causes, an all Party group of MPs and Peers says today. The Chair of the All Party Group on Smoking and Health, Paul Burstow MP (Sutton and Cheam: Liberal Democrat) is to introduce a “Tobacco Manufacturers (Producer Responsibility) Bill” on Monday 23rd March, under the Ten Minute Rule. The Bill will mark the start of a cross-Party campaign on how to use money from a levy on the tobacco industry. [More]
Experts call for a tobacco-free world by 2040

Experts call for a tobacco-free world by 2040

Leading public health researchers have called for the sale of tobacco to be phased out by 2040, showing that with sufficient political support and stronger evidence-based action against the tobacco industry, a tobacco-free world – where less than 5% of adults use tobacco – could be possible in less than three decades. [More]
Advertisement